Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 11, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on… Read More
In the global healthcare landscape, effective communication is paramount for ensuring optimal patient care and well-being. However, the linguistic diversity within patient populations poses… Read More
SAN FRANCISCO — A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials.
PARTNER 3 a… Read More
In workers’ compensation cases, resolutions usually find their way through settlements. Do All Workers’ Compensation Cases End in a Settlement? But does every journey end there?… Read More
Treatment with ozanimod (Zeposia) led to clinically meaningful improvement in cognitive processing speed among people with early relapsing multiple sclerosis (RMS), an ad hoc interim analy… Read More
BOSTON — Vaccine candidates for chikungunya virus and for the ubiquitous cytomegalovirus performed well in human clinical trials, researchers reported here at the annual IDWeek mee… Read More
Unraveling the Ozempic Mystery: Health Risks and Legal Implications
In the intricate world of pharmaceuticals, understanding the nuances of medications, including Ozempic with weight loss cl… Read More
CLEVELAND — Whether vagal nerve stimulation improved outcomes for heart failure patients with reduced ejection fraction (HFrEF) remained unclear after ANTHEM-HFrEF was terminated e… Read More
Delhi, 4th Oct, 2023: Following the tremendous success of the first roundtable, Peer Capital, 2070 Health, and Amazon Web Services (AWS) got together for a second edition of ‘HealthCra… Read More